In this prospective registry study, patients with low-, intermediate- and high-risk tumor entities as well as patients with high symptom burden of any tumor entity in palliative constellation with indication for radiation treatment are included. This radiation treatment can be applied either as 3D-conformal RT or IGRT. The duration of treatment can range from one day to several weeks. For the primary endpoint as well as the secondary clinical and other exploratory endpoints, the 3 groups will be compared in terms of DR, QoL, toxicities and treatment plan parameters
Indication for radiotherapy
Patient information and declaration of consent
Patients age ≥ 18 years
previous radiotherapy in affected site or same localisation in group 1-3
Inability to answer the questionnaires
Pre-existing conditions with increased risk of acute or late toxicity (LiFraumeni, Crohn's disease, ulcerative colitis)
Simultaneous participation in other studies that could interfere with this study and/or participation before expiry of a required restriction period